Preventing and treating cancers in people living with HIV
Consortium for Advancing Management and Prevention of Cancer in People with HIV
This network tests new prevention and treatment approaches to lower cancer risk and improve care for people living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11406615 on NIH RePORTER |
What this research studies
If you live with HIV, this consortium runs clinical trials at hospitals and clinics around the U.S., sub‑Saharan Africa, and Latin America to try new cancer prevention and treatment approaches. Researchers enroll people into clinical trials, collect blood and tissue samples for lab studies, and follow participants over time to see how well interventions work. The network includes translational labs that study tumor biology and a community advisory board that helps shape trial priorities and consent materials. Participation options and eligibility vary by trial, and the consortium supports sites in both high-income and low‑middle income settings.
Who could benefit from this research
Good fit: Adults living with HIV who are at risk for or diagnosed with cancers commonly seen in HIV (for example anal cancer) and who can enroll at an AMC site are the typical candidates.
Not a fit: People without HIV, patients with cancers not included in AMC trials, or those unable to access participating sites may not see direct benefit from this consortium's work.
Why it matters
Potential benefit: If successful, this could lower cancer rates and lead to better treatments, improving survival and quality of life for people with HIV.
How similar studies have performed: Previous AMC trials have produced guideline-changing results, so this consortium builds on a track record of successful patient-focused research.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.